SCHEMBL19471683

SCHEMBL19471683

CC1CN(C(=O)OC(C)(C)C)CC1Oc1cccc(-c2cccc(C3OCCO3)c2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.37
▸ ABCB1 P08183 2/20 0.36
▸ BACE1 P56817 6/20 0.34
▸ RORC P51449 1/20 0.34
▸ PIK3CD O00329 2/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ HDAC6 Q9UBN7 2/20 0.33
▸ BACE2 Q9Y5Z0 2/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ USP19 O94966 1/20 0.33
▸ CACNB4 O00305 1/20 0.33
▸ CACNA1A O00555 1/20 0.33
▸ CACNA1G O43497 1/20 0.33
▸ CACNG3 O60359 1/20 0.33
▸ CACNA1F O60840 1/20 0.33
▸ CACNA1H O95180 1/20 0.33
▸ CACNB3 P54284 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19471684 1.00 USP30 (0.37) USP30ABCB1BACE1RORCPIK3CD
SCHEMBL17688083 0.90 CACNB4 (0.41) USP30ABCB1RORCPIK3CDGPR119
SCHEMBL19471429 0.88 NR1H2 (0.35) USP30ABCB1PIK3CDSCN9AUSP19
SCHEMBL19471412 0.86 PIK3CD (0.42) USP30PIK3CDSCN9AGPR119USP19
SCHEMBL19471411 0.86 PIK3CD (0.42) USP30PIK3CDSCN9AGPR119USP19
SCHEMBL17687878 0.85 PIK3CD (0.44) PIK3CDGPR119
SCHEMBL17687943 0.85 PIK3CD (0.44) PIK3CDGPR119
SCHEMBL17687945 0.85 PIK3CD (0.44) PIK3CDGPR119
SCHEMBL19471630 0.84 ALOX5AP (0.39) USP30GPR119USP19
SCHEMBL17688085 0.83 USP30 (0.44) USP30PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3207042-B1 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION IDORSIA PHARMACEUTICALS LTD (CH) 2018-10-03 — — EP disclosed
US-9850256-B2 Antibacterial basic biaromatic derivatives with aminoalkoxy substitution IDORSIA PHARMACEUTICALS LTD (CH) 2017-12-26 — — US disclosed
US-20170305927-A1 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION IDORSIA PHARMACEUTICALS LTD (CH) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305927-A1 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION RPSA, RPL4, RPS4Y1 USP30 1237/4885ABCB1 1334/4885BACE1 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback